The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
Independent Grants for Learning & Change (IGLC) Track 2 - Call for Grant Applications (CGA): Enabling Patient Education in Relation to Oncology Biosimilars in Europe
The mission of Pfizer Independent Grants for Learning & Change (IGL&C) is to partner with the global healthcare community to improve patient outcomes in areas of mutual interest through support of measurable learning and change strategies. “Independent” means that the projects funded by Pfizer are the full responsibility of the recipient organization. Pfizer has no influence over any aspect of the projects and only asks for reports about the results and the impact of the projects in order to share them publicly. Through this CGA we encourage organizations to submit grant requests that, if funded, will support education in a specific disease state, therapeutic area, or broader area of educational need. Educational activities should not be focused on products specific to Pfizer.
Patient education leading to a clear understanding of oncology biosimilars. The intent of this CGA is to support educational programs that seek to improve patient knowledge and understanding related to oncology biosimilars in the European countries listed in the “Geographic Scope”section of this document.
Deadline: Apr. 2, 2018
Areas of Interest
Geographic Scope: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Israel, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey and United Kingdom.
Geographic Scope: Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Luxembourg, Malta, Netherlands, Norway, Portugal, Slovakia, Slovenia, Spain, Sweden, and United Kingdom
The following may apply: patients' organizations/patient advocacy groups, medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to public / patient health education and/or healthcare improvement.
A maximum budget of $140,000 (One hundred and Forty Thousand US Dollars) is available. This may be allocated to an individual project of high educational value or split between projects. The grant amount Pfizer will be prepared to fund will depend upon the evaluation of the proposal and costs involved and will be stated clearly in the approval notification